Viral antigen manufacturers are largely focusing on the development of antiviral diagnostics and treatments for a variety of chronic ailments, gene therapy, or vaccinology extending the scope of application.
ROCKVILLE, MD / ACCESSWIRE / September 1, 2020 / The viral antigens market is projected to reflect an impressive 9% CAGR through the period of forecasting between 2020 and 2030. The coronavirus pandemic is anticipated to have a positive influence on the viral antigens market. Growing global demand for rapid diagnostic testing for the covid-19 virus, with an unprecedented number of patients will boost short term market growth.
“Rise in incidences of numerous non-infectious and infectious ailments, coupled with tech advancements are likely to provide impetus to the global viral antigens market, in combination with the rising number of associated public and private initiatives such as vaccination programs for the long term, ” says the Fact.MR report.
Request a sample of the report to gain more market insights at
Viral Antigens Market – Key Takeaways
- Recombinant viral antigens are gaining increased interest owing to lower risk of false negatives and rising role in personalized medical care.
- Contract research organizations account for major users of viral antigens, supported by demand for low-cost, R&D vaccinology efforts.
- North America is a prominent market for viral antigens, promoted by favorable government initiatives towards biomedicine.
Viral Antigens Market – Driving Factors
- Easy of viral antigen production processes and quality control are favorable to market growth.
- Low toxicity of viral antigens and potential applications, even when viruses cannot be cultivated support adoption
Viral Antigens Market – Constraints
- Strict government regulations on the approval of antigens is a major hinderance to market growth.
- Poor reimbursement infrastructure associated to vaccinations indirectly impact demand for viral antigens.
Anticipated Market Impact by Coronavirus Outbreak
The impact of the covid-19 outbreak on the viral antigen market is largely positive, owing to the massive demand for applications in rapid diagnostic testing kits, and for vaccine development efforts. With millions of active cases of coronavirus around the world, the application of viral antigens for early detection and monitoring of patients support demand. Market players are likely to focus on expanding production capacities during this period. Market prospects are likely to remain bright in the long term with demand for treating other chronic and infectious ailments.
Explore the global viral antigens market with 118 figures, 41 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/1305/viral-antigens-market
Major manufacturers in the viral antigens market include but are not limited to ACROBiosystems Inc., Microbix Biosystems Inc., ProSpec-Tany TechnoGene Ltd., Creative Diagnostics, Viral Antigens Inc., Bio Rad Laboratories, Advanced Biotechnologies Inc., Aalto Bio Reagents, and Novartis Diagnostics.
Leading players in the viral antigens market are pushing for the expansion of manufacturing capacities and the expansion of product portfolios to bolster scope of application for treatments and diagnostics to multiple ailments.
For instance, Microbix Biosystems Inc. has announced the initiation of six bioreactor units for production of antigens for rubella virus immunoassays. Native Antigen Co. has unveiled a contract agency towards the manufacture of flu An and B antigens in short time frames. Also, Novartis Diagnostics has received EMA approval for CAR-T antigen manufacturing sites in Europe in France and Switzerland.
More on the Report
The FACT.MR’s market research report provides in-depth insights on viral antigens market. The market is scrutinized according to component (influenza, coronavirus, zika, ebola, dengue, herpes simplex virus, rotavirus, Epstein-barr, hepatitis A-E, parainfluenza, measles, adenovirus, mumps, varicella zoster, and others), technique (ELISA, immunoassay, hemagglutination, radioimmunoassay, immunoperoxidase staining, immunofluorescence, electron microscopy, and others), and end user (hospital, clinics, laboratories, diagnostic centers, and blood banks, and research institutes) across seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa).
Explore Wide-ranging Coverage of FACT.MR’s Healthcare Landscape
Antibodies Market: Find insights on the global antibodies market with analysis of segments, statistics, influencers, market players and business strategies adopted over a 5-year forecast period.
Bacterial Antigens Market: FACT.MR’s report on the bacterial antigens market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.
Fungal Antigens Market: Read an analysis on the fungal antigens market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.
Expert analysis, actionable insights, and strategic recommendations of the veteran research team at Fact.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Fact.MR’s latest market reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.
11140 Rockville Pike
Rockville, MD 20852
View source version on accesswire.com: